Johnson & Johnson shares fell slightly Thursday after soaring yesterday amid investor optimism about the company's ...

The healthcare company's payout currently yields 3.3%, more than double the S&P 500 's ( ^GSPC 0.32%) dividend yield (near a ...

CNBC’s Jim Cramer explained what made shares of Johnson & Johnson rise after the company posted its quarterly report.

J&J's stock price is down from its 2022 peak, but it's performed better than you might think by simply looking at its chart.

Johnson & Johnson revised its fiscal year 2025 guidance. The company expects adjusted earnings of $10.80-$10.90, up from ...

J&J's diversified business, robust pipeline, and strong free cash flow provide stability, despite legal challenges. Read more ...